The Pollack Lab is a cancer immunology lab under Northwestern University’s Feinberg School of Medicine dedicated to curing sarcomas. The lab’s ground-breaking work has led to important discoveries resulting in multiple clinical trials that are actively shaping the care of sarcoma patients worldwide. Furthermore, through the careful study of these unique cancers, the lab has uncovered fundamental insights shaping the development of immunotherapy for all cancers.
Dr. Seth Pollack is an expert sarcoma specialist serving as the Director of the Sarcoma Program at the Lurie Cancer Center and the Steven T. Rosen Professor of Cancer Biology at the Feinberg School of Medicine. He is developing new immunotherapies for patients with sarcoma. His work, targeting cancer-specific proteins, has led to important breakthroughs in our understanding of the sarcoma immune microenvironment. He has led important early-stage sarcoma immunotherapy trials and his publications have helped to shape the present state of sarcoma clinical care.